Large-scale protein-disease risk association analysis in the UK Biobank

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Assistant Professor Sarantis Chlamydas

Thermo Fisher Scientific, Frankfurt am Main (Germany)

7 More presentations in this session

Presentation thumbnail

MicroRNA signatures in diabetes and myocardial infarction: in silico prediction and bench-to-bedside analysis

Ms S. Ahmadova (Warsaw, PL)

Abstract Slides Video

Presentation thumbnail

Kynurenine is a prognostic biomarker in pulmonary infections with association to cardiac dysfunction

Doctor A. Puetz (Aachen, DE)

Abstract Slides Video

Presentation thumbnail

Examining the predictive value of plasma lysozyme for future all-cause mortality

Doctor S. Fathieh (London, GB)

Abstract Slides Video

Presentation thumbnail

Low cellular fibronectin levels are associated with bleeding in patients with atrial fibrillation: a long-term observational study

Miss K. Gladys (Cracow, PL)

Abstract Slides Video

Presentation thumbnail

Integrated Impact of hs-CRP, LDL-C and Lp(a) on Platelet Reactivity in Coronary Heart Disease Patients Receiving Dual Antiplatelet Therapy

Ms J. Li (Beijing, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Biomarkers and molecular predictors in cardiovascular disease: from risk assessment to clinical application

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

From proteomics to precision: protein signatures as surrogate markers in phase II heart failure trials. A subanalysis from MYSTERY-HF

Congress Presentation

Biomarker research in Circulation

Congress Presentation

Evaluating off-target drug effects seen in RCTs using proteomics and mendelian randomisation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources